EUVIMEDEUVIMED entdecken
Crossref

Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy

Peng Xie, Qiao Jin, Lingpu Zhang, Hanchen Zhang, Nicolás Montesdeoca, Johannes Karges iD, Haihua Xiao iD, Xinzhan Mao, Haiqin Song iD, Kun Shang

ACS Nano · 28.05.2024 · 18 (21) · 13683-13695

DOI: 10.1021/acsnano.4c01352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 15.05.2024. Verfasst von Peng Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Fluorocarbons, Antineoplastic Agents, Serum Albumin, Human, Immunotherapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Fonds der Chemischen Industrie, National Natural Science Foundation of China, Guangci Distinguished Young Scholars Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorocarbonsAntineoplastic AgentsSerum Albumin, HumanImmunotherapyHumansAnimalsMiceCisplatinCell Line, TumorNanoparticlesProdrugsCell ProliferationPlatinumMice, Inbred BALB CImmunogenic Cell Death

Stichwörter der Autor:innen

bioinorganic chemistrychemoimmunotherapyimmunogenic cell deathmedicinal inorganic chemistrymetals in medicine

Substanzen

FluorocarbonsAntineoplastic AgentsSerum Albumin, HumanCisplatinProdrugsPlatinum

Autor:innen und Institutionen

  • Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Department of Oncology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
  • Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, Bochum 44780, Germany.
  • Department of General Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 20025, China.
  • Department of Nuclear Medicine, Peking University People's Hospital, Beijing 100044, China.

ORCID-Profile: Johannes Karges, Haihua Xiao, Haiqin Song

Förderung

  • Fonds der Chemischen Industrie
  • National Natural Science Foundation of China
  • Guangci Distinguished Young Scholars Training Program

Zitieren

APA

Xie, P., Jin, Q., Zhang, L., Zhang, H., Montesdeoca, N., Karges, J., Xiao, H., Mao, X., Song, H., & Shang, K. (2024). Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy. ACS Nano, 18(21), 13683-13695. https://doi.org/10.1021/acsnano.4c01352

Vancouver

Xie P, Jin Q, Zhang L, Zhang H, Montesdeoca N, Karges J, et al. Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy. ACS Nano. 2024;18(21):13683-13695. doi:10.1021/acsnano.4c01352

BibTeX
@article{Xie2024,
  author = {Xie, Peng and Jin, Qiao and Zhang, Lingpu and Zhang, Hanchen and Montesdeoca, Nicolás and Karges, Johannes and Xiao, Haihua and Mao, Xinzhan and Song, Haiqin and Shang, Kun},
  title = {Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {21},
  pages = {13683--13695},
  doi = {10.1021/acsnano.4c01352}
}
Kostenlos starten →